Panagora Asset Management’s KalVista Pharmaceuticals KALV Stock Holding History

Panagora Asset Management’s Portfolio KALV Stock Details KALV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.02M	Sell	50,792 -58,599	-54%	-$944K	﹤0.01%	706
2025 Q4	$1.77M	Sell	109,391 -87,944	-45%	-$1.16M	0.01%	596
2025 Q3	$2.4M	Sell	197,335 -95,258	-33%	-$1.32M	0.01%	483
2025 Q2	$3.31M	Buy	292,593 +220,697	+307%	+$2.7M	0.01%	385
2025 Q1	$830K	Hold	71,896	–	–	﹤0.01%	699
2024 Q4	$609K	Buy	+71,896	New	+$745K	﹤0.01%	783
2023 Q4	–	Sell	-22,941	Closed	-$221K	–	1260
2023 Q3	$221K	Sell	22,941 -3,149	-12%	-$32.2K	﹤0.01%	1151
2023 Q2	$235K	Sell	26,090 -20,159	-44%	-$186K	﹤0.01%	1154
2023 Q1	$364K	Buy	46,249 +27,381	+145%	+$204K	﹤0.01%	1211
2022 Q4	$128K	Buy	+18,868	New	+$101K	﹤0.01%	1402
2021 Q3	–	Sell	-278	Closed	-$7K	–	2055
2021 Q2	$7K	Sell	278 -23	-8%	-$602	﹤0.01%	2375
2021 Q1	$8K	Hold	301	–	–	﹤0.01%	2465
2020 Q4	$6K	Buy	+301	New	+$5.16K	﹤0.01%	2417
2017 Q4	–	Sell	-2,274	Closed	-$15K	–	2324
2017 Q3	$15K	Buy	2,274 +1,666	+274%	+$11.9K	﹤0.01%	2212
2017 Q2	$4K	Buy	+608	New	+$4.47K	﹤0.01%	2523
2015 Q4	–	Sell	-11,518	Closed	-$576K	–	2332
2015 Q3	$576K	Sell	11,518 -3,279	-22%	-$280K	﹤0.01%	1265
2015 Q2	$1.48M	Buy	+14,797	New	+$1.47M	0.01%	924

Other funds holding KALV

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Panagora Asset Management's KALV Position: Q1 2026 in Review

Panagora Asset Management reduced its KalVista Pharmaceuticals (KALV) stake by 54% in Q1 2026, selling an estimated $944K and leaving 50,792 shares worth $1.02M. The position accounts for ﹤0.01% of the portfolio, ranked #706.

Panagora Asset Management first reported a position in KALV in Q2 2015 and has held it in 17 quarters since. The position peaked at $3.31M in Q2 2025. 183 funds tracked by Wall St. Rank hold KALV as of Q1 2026.

Panagora Asset Management held 50,792 shares of KalVista Pharmaceuticals worth $1.02M as of Q1 2026.
Panagora Asset Management sold 58,599 KalVista Pharmaceuticals shares in Q1 2026, an estimated $944K.
KalVista Pharmaceuticals made up ﹤0.01% of Panagora Asset Management's portfolio in Q1 2026, its #706 holding.
Panagora Asset Management first reported a position in KalVista Pharmaceuticals in Q2 2015 and has held it in 17 quarters since.
Panagora Asset Management's KalVista Pharmaceuticals position peaked at $3.31M in Q2 2025.
183 funds tracked by Wall St. Rank held KalVista Pharmaceuticals as of Q1 2026.

Based on Panagora Asset Management's 13F filing for Q1 2026, filed 14 May 2026.